Search Results (1 to 4 of 4 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Formative Research
- 1 JMIR Public Health and Surveillance
- 1 JMIR Research Protocols
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)

The Tough Talks COVID (TT-C) study was a randomized controlled trial of a DHI designed to empower Black young adults in the United States South to make informed, autonomous decisions about COVID-19 vaccine uptake (Clinical Trials.gov NCT05490329) [30]. The TT-C intervention was cocreated using community-based participatory research methods to address structural barriers and misinformation about vaccines through interactive activities and digital storytelling [31,32].
JMIR Public Health Surveill 2025;11:e67370
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section

Considering these factors, we developed this protocol to adapt a previously developed DHI in the domain of HIV status disclosure (Tough Talks) to a COVID-19 vaccine decision-making context (Tough Talks for COVID-19 [TT-C]) [25]. The TT-C intervention aims to enable Black young adults in the southern United States to make informed, autonomous decisions about COVID-19 vaccine receipt via nonstigmatizing and tailored messaging.
JMIR Res Protoc 2023;12:e41240
Download Citation: END BibTex RIS
Go back to the top of the page Skip and go to footer section